Article
Protease inhibitors-based therapy induces acquired spherocytic-like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients.
Liver international : official journal of the International Association for the Study of the Liver - 1 Jan 2016
Lupo Francesca, Russo Roberta, Iolascon Achille, Ieluzzi Donatella, Siciliano Angela, Toniutto Pierluigi, Matté Alessandro, Piovesan Sara, Raffetti Elena, Turrini Francesco, Dissegna Denis, Donato Francesco, Alberti Alfredo, Zuliani Valeria, Fattovich Giovanna, De Franceschi Lucia
Abstract excerpt
BACKGROUND & AIMS: The addition of protease inhibitors, boceprevir (BOC) or telaprevir (TRV), to peg-interferon and ribavirin (PR) increases the incidence of anaemia in patients with chronic hepatitis C virus (HCV) infection. Although genetic variants in inosine triphosphatase (ITPA) gene have be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
